T CELL RECONSTITUTION AFTER STEM CELL AUTOGRAFTING

干细胞自体移植后 T 细胞重建

基本信息

  • 批准号:
    6613452
  • 负责人:
  • 金额:
    $ 29.93万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1999
  • 资助国家:
    美国
  • 起止时间:
    1999-07-01 至 2004-12-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION: (Verbatim from Investigator's abstract): Background: The recovery of CD4 T cells after high-dose chemo/radiotherapy in adult patients with cancer or autoimmune diseases is very slow (years) and may result in only limited T cell repertoire. A similar problem exists in AIDS patients treated with highly active anti-retroviral therapy. With the ultimate goal of designing strategies to improve the T cell regeneration after T lymphocytopenia, here we propose to study the mechanism of the T cell regeneration. Hypothesis: We hypothesize that after T-lymphocytopenia a substantial number of regenerating T cells originate from hemopoietic progenitors in young individuals whereas only few, if any, T cells originate from hemopoietic progenitors in older individuals. Instead, in the older individuals, the vast majority of T cells originate from the expansion of preexisting T cells. Methods: This hypothesis will be tested in severely lymphocytopenic patients with autoimmune diseases who have received high-dose chemo/radiotherapy plus anti-thymocyte globulin followed by autologous transplantation of hemopoietic (CD34+) cells. An extremely limited number of T cell clones survive such transplant conditioning/ CD34+ cell purification. Therefore, it is relatively easy (easier and more informative than in patients with only moderate T lymphocytopenia) to track down the fate of the surviving T cell clones and to detect T cells newly generated from hemopoietic progenitors post-transplant, using the following techniques: spectratyping, sequencing of the T cell receptor genes within a single spectratyping band, and quantifying T cells that contain T cell receptor-rearrangement excision circles (TREC). Outcome: If the above hypothesis is true, the repertoire of T cells, that is severely limited within the first several months after transplant, will later diversify in young (less than 5-years-old) whereas it will stay severely limited in older (greater than 45-years-old) patients. Also, if the hypothesis is true, the number of TREC-containing T cells post-transplant will be significantly higher in the young compared to the older patients. This will give impetus for developing strategies to enable older patients to generate T cells from hemopoietic progenitors, e.g., using thymopoietic cytokines or thymus grafting.
描述:(逐字摘自研究者摘要):

项目成果

期刊论文数量(4)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Transgene expression by a large fraction of dendritic cells following autologous transplantation of retrovirally transduced CD34 cells.
逆转录病毒转导的 CD34+ 细胞自体移植后,大部分树突状细胞进行转基因表达。
  • DOI:
    10.1089/scd.2006.15.619
  • 发表时间:
    2006
  • 期刊:
  • 影响因子:
    4
  • 作者:
    Storek,Jan;Kiem,Hans-Peter
  • 通讯作者:
    Kiem,Hans-Peter
Early recovery of CD4 T cell receptor diversity after "lymphoablative" conditioning and autologous CD34 cell transplantation.
“淋巴清除”调理和自体 CD34 细胞移植后 CD4 T 细胞受体多样性的早期恢复。
Normal interleukin-7 (IL7) levels and normal IL7 response to CD4 T lymphopenia in patients with multiple sclerosis and systemic sclerosis.
多发性硬化症和系统性硬化症患者的正常白介素 7 (IL7) 水平以及对 CD4 T 淋巴细胞减少症的正常 IL7 反应。
  • DOI:
    10.1016/j.clim.2006.05.016
  • 发表时间:
    2006
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Storek,Jan;Nash,RichardA;McSweeney,PeterA;Furst,DanielE;Sullivan,KeithM
  • 通讯作者:
    Sullivan,KeithM
Long-term response of juvenile idiopathic arthritis after conditioning with 8 Gy total body irradiation followed by autologous peripheral blood stem cells: case report.
幼年特发性关节炎经 8 Gy 全身照射后自体外周血干细胞调理后的长期反应:病例报告。
  • DOI:
    10.1111/j.1399-3046.2009.01129.x
  • 发表时间:
    2010
  • 期刊:
  • 影响因子:
    1.3
  • 作者:
    Woolfrey,Ann;Storek,Jan;Bowyer,Suzanne;Nelson,Robert;Robertson,Michael;Wallace,Carol
  • 通讯作者:
    Wallace,Carol
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JAN STOREK其他文献

JAN STOREK的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('JAN STOREK', 18)}}的其他基金

T CELL REGENERATION IN PRIMATES
灵长类动物 T 细胞再生
  • 批准号:
    6940136
  • 财政年份:
    2003
  • 资助金额:
    $ 29.93万
  • 项目类别:
Preclinical Testing of Interleukin-7 in Primates
Interleukin-7 在灵长类动物中的临床前测试
  • 批准号:
    6319291
  • 财政年份:
    2001
  • 资助金额:
    $ 29.93万
  • 项目类别:
Preclinical Testing of Interleukin-7 in Primates
Interleukin-7 在灵长类动物中的临床前测试
  • 批准号:
    6528196
  • 财政年份:
    2001
  • 资助金额:
    $ 29.93万
  • 项目类别:
Preclinical Testing of Interleukin-7 in Primates
Interleukin-7 在灵长类动物中的临床前测试
  • 批准号:
    6644818
  • 财政年份:
    2001
  • 资助金额:
    $ 29.93万
  • 项目类别:
T CELL RECONSTITUTION AFTER STEM CELL AUTOGRAFTING
干细胞自体移植后 T 细胞重建
  • 批准号:
    6017567
  • 财政年份:
    1999
  • 资助金额:
    $ 29.93万
  • 项目类别:
T CELL RECONSTITUTION AFTER STEM CELL AUTOGRAFTING
干细胞自体移植后 T 细胞重建
  • 批准号:
    6374275
  • 财政年份:
    1999
  • 资助金额:
    $ 29.93万
  • 项目类别:
T CELL RECONSTITUTION AFTER STEM CELL AUTOGRAFTING
干细胞自体移植后 T 细胞重建
  • 批准号:
    6510906
  • 财政年份:
    1999
  • 资助金额:
    $ 29.93万
  • 项目类别:
T CELL RECONSTITUTION AFTER STEM CELL AUTOGRAFTING
干细胞自体移植后 T 细胞重建
  • 批准号:
    6170806
  • 财政年份:
    1999
  • 资助金额:
    $ 29.93万
  • 项目类别:
B CELL TRANSFUSIONS FOR POSTBMT IMMUNE DEFICIENCY
B 细胞输注治疗 TBMT 后免疫缺陷
  • 批准号:
    2112477
  • 财政年份:
    1995
  • 资助金额:
    $ 29.93万
  • 项目类别:
B CELL TRANSFUSIONS FOR POSTBMT IMMUNE DEFICIENCY
B 细胞输注治疗 TBMT 后免疫缺陷
  • 批准号:
    2895387
  • 财政年份:
    1995
  • 资助金额:
    $ 29.93万
  • 项目类别:

相似海外基金

SIGNAL TRANSDUCTION VIA THE CD4 MOLECULE
通过 CD4 分子进行信号转导
  • 批准号:
    3455200
  • 财政年份:
    1989
  • 资助金额:
    $ 29.93万
  • 项目类别:
SIGNAL TRANSDUCTION VIA THE CD4 MOLECULE
通过 CD4 分子进行信号转导
  • 批准号:
    3455198
  • 财政年份:
    1989
  • 资助金额:
    $ 29.93万
  • 项目类别:
SIGNAL TRANSDUCTION VIA THE CD4 MOLECULE
通过 CD4 分子进行信号转导
  • 批准号:
    3455199
  • 财政年份:
    1989
  • 资助金额:
    $ 29.93万
  • 项目类别:
SIGNAL TRANSDUCTION VIA THE CD4 MOLECULE
通过 CD4 分子进行信号转导
  • 批准号:
    2064344
  • 财政年份:
    1989
  • 资助金额:
    $ 29.93万
  • 项目类别:
SIGNAL TRANSDUCTION VIA THE CD4 MOLECULE
通过 CD4 分子进行信号转导
  • 批准号:
    3455197
  • 财政年份:
    1989
  • 资助金额:
    $ 29.93万
  • 项目类别:
SIGNAL TRANSDUCTION VIA THE CD4 MOLECULE
通过 CD4 分子进行信号转导
  • 批准号:
    3455196
  • 财政年份:
    1989
  • 资助金额:
    $ 29.93万
  • 项目类别:
MOUSE MONOCLONAL ANTIBODIES AGAINST HUMAN CD4 MOLECULE GENERATE MONOCLONAL ANT
抗人 CD4 分子的小鼠单克隆抗体生成单克隆蚂蚁
  • 批准号:
    3810218
  • 财政年份:
  • 资助金额:
    $ 29.93万
  • 项目类别:
MOUSE MONOCLONAL ANTIBODIES AGAINST HUMAN CD4 MOLECULE
针对人 CD4 分子的小鼠单克隆抗体
  • 批准号:
    3803662
  • 财政年份:
  • 资助金额:
    $ 29.93万
  • 项目类别:
MOUSE MONOCLONAL ANTIBODIES AGAINST HUMAN CD4 MOLECULE GENERATE MONOCLONAL ANT
抗人 CD4 分子的小鼠单克隆抗体生成单克隆蚂蚁
  • 批准号:
    3814788
  • 财政年份:
  • 资助金额:
    $ 29.93万
  • 项目类别:
MOUSE MONOCLONAL ANTIBODIES AGAINST HUMAN CD4 MOLECULE GENERATE MONOCLONAL ANT
抗人 CD4 分子的小鼠单克隆抗体生成单克隆蚂蚁
  • 批准号:
    3818867
  • 财政年份:
  • 资助金额:
    $ 29.93万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了